Cite
HARVARD Citation
Rulach, R. et al. (2020). Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions. Clinical oncology. 32 (4), pp. 250-258. [Online].